Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

13,987 total articles

Trump’s Certification Threat Sends Bombardier Shares Lower as Analysts Dismiss Enforcement Risk

Trump’s Certification Threat Sends Bombardier Shares Lower as Analysts Dismiss Enforcement Risk

Bombardier Inc. shares plunged after a late social media directive from the U.S. President threatened to decertify Canadian-made aircraft and impose a 50% tariff on future sales. Analysts at Desjardins see the threat as unlikely to be enforceable, citing limited outstanding approvals and the complexity of decertifying aircraft already operating in …

Once Upon A Farm IPO Draws Robust Institutional Interest Ahead of Pricing

Once Upon A Farm IPO Draws Robust Institutional Interest Ahead of Pricing

Once Upon A Farm PBC, the organic kids' food company co-founded by actress Jennifer Garner, has generated notable demand for an initial public offering of up to $209 million during one-on-one investor meetings ahead of pricing scheduled for next week. The company intends to list on the New York Stock Exchange under the ticker OFRM, with Goldman Sac…

U.S. Equity Funds See Renewed Inflows Ahead of Mega-Cap Earnings

U.S. Equity Funds See Renewed Inflows Ahead of Mega-Cap Earnings

U.S. equity mutual funds and ETFs recorded net inflows in the week ending January 28, reversing the prior week's redemptions and driven by optimism ahead of major technology company earnings. Sector-specific funds logged their largest weekly net investments since at least 2022, while bond and money-market funds also attracted fresh capital.

Eli Lilly to Spend $3.5 Billion on Pennsylvania Manufacturing Site for Injectable Weight-Loss Drugs

Eli Lilly to Spend $3.5 Billion on Pennsylvania Manufacturing Site for Injectable Weight-Loss Drugs

Eli Lilly said it will construct a $3.5 billion pharmaceutical plant in Pennsylvania to produce injectable weight-loss medicines, including retatrutide. The facility - the company’s fourth new U.S. site in a multi-site expansion - is slated to begin construction in 2026 and become operational in 2031. The investment, chosen from more than 300 appli…

Wolfe Raises Nvidia Price Target to $275 Citing Rack-Scale Momentum

Wolfe Raises Nvidia Price Target to $275 Citing Rack-Scale Momentum

Wolfe Research increased its Nvidia price target to $275 from $250, based on supply-chain checks and modeling that emphasize rack-scale deployments, rising average selling prices and persistent gross margins. The firm projects substantial Blackwell and Rubin rack volumes, strong GPU unit growth through 2027, and very large data center revenue figur…